PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Bacterial infection (Ceftazidime pentahydrate - Bacterial infection)

Records returned : 67 (on 25 Nov 2024 at 03:39:30). .

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
05.01.02
11.03.01
Ceftazidime pentahydrate
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. F Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Doxycycline
Bacterial infection
Green
Formulations :
  • Capsules
  • Dispersible tablets
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials.
05.01.01
Amoxicillin
Bacterial infection
Green
Formulations :
  • Capsules
  • Oral suspension
  • Sachets (SUGAR FREE powder)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
05.01.05
Azithromycin
Bacterial infection
Green
Formulations :
  • Capsules
  • Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
05.01.01
Benzylpenicillin sodium (Penicillin G)
Bacterial infection
Green
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
05.01.02
Cefalexin
Bacterial infection
Green
Formulations :
  • Capsules
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
05.01.02
Cefotaxime sodium
Bacterial infection
Green
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
05.01.02
Ceftriaxone sodium
Bacterial infection
Green
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available. Primary care use restricted to IM injection to treat gonorrhoea.
05.01.12
11.03.01
Ciprofloxacin
Bacterial infection
Green
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
05.01.05
Clarithromycin
Bacterial infection
Green
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
Co-amoxiclav
Bacterial infection
Green
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials. Contra-indicated in Penicillin Allergy.
05.01.08
Co-trimoxazole(Trimethoprim/sulfamethoxazole)
Bacterial infection
Green
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials.
05.01.03
Doxycycline hyclate
Bacterial infection
Green
Formulations :
  • Capsules
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials.
05.01.05
Erythromycin
Bacterial infection
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
05.01.01
Flucloxacillin sodium
Bacterial infection
Green
Formulations :
  • Capsules
  • Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
Fosfomycin
Bacterial infection
Green
Formulations :
  • Granules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials.
05.01.12
11.03.01
Levofloxacin
Bacterial infection
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
05.01.11
07.02.02
Metronidazole
Bacterial infection
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials.
05.01.01
Phenoxymethylpenicillin (Penicillin V)
Bacterial infection
Green
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials
05.01.08
Trimethoprim
Bacterial infection
Green
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials.
05.01.13
Nitrofurantoin
Bacterial infection
Green
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
SA
Important
Follow local guidelines on the use of antimicrobials.
05.01.07
11.03.01
Fusidic acid
Bacterial infection
Blue
Formulations :
  • Suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Follow local guidelines on the use of antimicrobials. Use in primary care when indicated by microbiology eg on culture results,
05.01.02
Cefaclor
Bacterial infection
Blue
Formulations :
  • Capsules
  • Modified release tablets
  • Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialisit microbiology  recommendation.    Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available.  Use in primary care when indicated by microbiolgy eg on culture results,
Clindamycin
Bacterial infection
Blue
Formulations :
  • Capsules
  • Liquid
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Use in primary care when indicated by microbiology eg on culture results. Clindamycin has a high association with the development of Clostridium Difficile.  Patients and carers should be advised to stop clindamycin if diarrhoea develops. 
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Clindamycin has a high association with the development of Clostridium Difficile.  Patients and carers should be advised to stop clindamycin if diarrhoea develops.
05.01.01
Amoxicillin
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials. Contra-indicated in Penicillin Allergy.
05.01.12
11.03.01
Ciprofloxacin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
05.01.05
Erythromycin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
05.01.08
Co-trimoxazole(Trimethoprim/sulfamethoxazole)
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials.
Co-amoxiclav
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Contra-indicated in Penicillin Allergy.
05.01.05
Clarithromycin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Cetftolozone with tazobactam
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
05.01.02
11.03.01
Cefuroxime sodium
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
05.01.07
11.03.01
Chloramphenicol
Bacterial infection
Red
Formulations :
  • Capsules
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialisit microbiology recommendation.
05.01.07
Dalbavancin hydrochloride
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
05.01.07
Dapsone
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
05.01.07
Daptomycin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
05.01.03
Demeclocycline hydrochloride
Bacterial infection
Red
Formulations :
  • Capsules
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
05.01.02
05.01.07
Ertapenem sodium
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
05.01.04
11.03.01
Gentamicin sulfate
Bacterial infection
Red
Formulations :
  • Infusion
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
SA
Important
Follow local guidelines on the use of antimicrobials. This drug requires therapeutic monitoring
05.01.02
05.01.07
Imipenem with cilastatin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
05.01.02
05.01.07
Meropenem
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
SA
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
05.01.12
11.03.01
Moxifloxacin
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
05.01.12
Norfloxacin
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
05.01.01
Piperacillin sodium/tazobactam sodium
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Contra-indicated in Penicillin Allergy
05.01.09
Rifabutin
Bacterial infection
Red
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - requires microbiology or respiratory approval
05.01.07
Sodium fusidate
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
05.01.04
05.01.09
Streptomycin
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
05.01.08
Sulfadiazine
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Toxoplasmosis only
05.01.07
Teicoplanin
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials. This drug requires Therapeutic Drug Monitoring.
05.01.01
Temocillin sodium
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
05.01.03
Tigecycline
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
05.01.11
Tinidazole
Bacterial infection
Red
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Ceftazidime with avibactam
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
05.01.12
Ofloxacin
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
05.01.07
11.03.01
Vancomycin hydrochloride
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. This drug requires therapeutic monitoring.
05.01.04
11.03.01
Amikacin
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. This drug requires therapeutic monitoring
00.00.00
05.01.02
Aztreonam
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Restricted Use - for use when indicated by NICE guidelines, local trust antimicrobial guidelines or specialist microbiology recommendation
05.01.02
Cefepime
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
Cefiderocol
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
R
NICE
Important
Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
05.01.02
Cefixime
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
05.01.11
07.02.02
Metronidazole
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials
05.01.11
07.02.02
Bacterial infection
Red
Formulations :
  • Suppositories
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Follow local guidelines on the use of antimicrobials
05.01.12
11.03.01
Levofloxacin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Fosfomycin
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
05.01.01
Flucloxacillin sodium
Bacterial infection
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
Thalidomide
Bacterial infection
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD2
Important
on formulary for other non-infection indications
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More